Condom maker mulls US$300m IPO in city

The firm behind brands including Jissbon condoms is considering a Hong Kong initial public offering that could raise about US$300 million (HK$2.34 billion), according to people familiar with the matter.

Lifestyles Healthcare's China business, which was separated from the sexual wellness company's global operations when it was sold last year, is in talks with potential advisers for a listing as soon as this year, they said.

Jissbon's name is a Chinese translation of fictional British spy James Bond, the secret agent who was almost as famous for his sexual exploits as his missions to save the world.

Lifestyles Healthcare was created when a consortium bought the condom and lubricants maker from Australia's Ansell for US$600 million in 2017. In 2020, Hillhouse Capital, Boyu Capital and CareCapital Partners acquired a 40 percent stake in Lifestyles Healthcare for US$200 million.